116 related articles for article (PubMed ID: 27933575)
1. [Fast-acting insulin - new developments towards more flexibility for the patient].
Schmeisl GW; Kretzschmar Y
MMW Fortschr Med; 2016 Dec; 158(Suppl 6):5-11. PubMed ID: 27933575
[TBL] [Abstract][Full Text] [Related]
2. Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.
Christiansen JS; Liebl A; Davidson JA; Ligthelm RJ; Halimi S
Diabetes Obes Metab; 2010 Feb; 12(2):105-14. PubMed ID: 19895637
[TBL] [Abstract][Full Text] [Related]
3. Prandial Insulins: A Person-Centered Choice.
Attri B; Nagendra L; Dutta D; Shetty S; Shaikh S; Kalra S; Bhattacharya S
Curr Diab Rep; 2024 Jun; 24(6):131-145. PubMed ID: 38568467
[TBL] [Abstract][Full Text] [Related]
4. [Insulin therapy-new insulin analogues].
Ehren M; Klein HH
Internist (Berl); 2019 Sep; 60(9):887-894. PubMed ID: 31396651
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological treatment of postprandial hyperglycemia].
Blickle JF
Diabetes Metab; 2000 Jun; 26 Suppl 2():20-4. PubMed ID: 10975046
[TBL] [Abstract][Full Text] [Related]
6. [Insulin therapy in type 1 diabetes].
Philips JC; Radermecker RP
Rev Med Liege; 2005; 60(5-6):322-8. PubMed ID: 16035288
[TBL] [Abstract][Full Text] [Related]
7. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
Rolla AR; Rakel RE
Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
[TBL] [Abstract][Full Text] [Related]
8. [Insulin therapy].
Brunetti P
Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
[TBL] [Abstract][Full Text] [Related]
9. Intensification with prandial insulin.
Pfützner A; Forst T
Int J Clin Pract Suppl; 2009 Oct; (164):11-4. PubMed ID: 19751454
[TBL] [Abstract][Full Text] [Related]
10. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
Shaefer CF; Anderson J
Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
Rolla A
Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
[TBL] [Abstract][Full Text] [Related]
12. Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.
Schmoelzer I; de Campo A; Pressl H; Stelzl H; Dittrich P; Oettl K; Wascher TC
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):176-81. PubMed ID: 15789278
[TBL] [Abstract][Full Text] [Related]
13. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
[TBL] [Abstract][Full Text] [Related]
14. Current strategies for controlling postprandial hyperglycaemia.
Kunt T
Int J Clin Pract Suppl; 2001 Sep; (123):19-23. PubMed ID: 11594292
[TBL] [Abstract][Full Text] [Related]
15. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
Robertson C
Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
[TBL] [Abstract][Full Text] [Related]
16. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz HE
Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
[TBL] [Abstract][Full Text] [Related]
17. The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart.
Ceriello A; Cavarape A; Martinelli L; Da Ros R; Marra G; Quagliaro L; Piconi L; Assaloni R; Motz E
Diabet Med; 2004 Feb; 21(2):171-5. PubMed ID: 14984453
[TBL] [Abstract][Full Text] [Related]
18. Post-prandial glycemic control: molecular targets for pharmacological intervention.
Chandalia HB
J Assoc Physicians India; 2001 Jan; 49 Spec No():11-6. PubMed ID: 11235597
[No Abstract] [Full Text] [Related]
19. [Renewed interest for the control of post-prandial hyperglycaemia].
Vandelaer A; Joubert M; Philips JC
Rev Med Suisse; 2022 Aug; 18(792):1560-1564. PubMed ID: 36004657
[TBL] [Abstract][Full Text] [Related]
20. [Postprandial hyperglycemia. II. Pharmacological approaches].
Scheen AJ; Letiexhe MR; Geronooz I; Paquot N; Jandrain B
Rev Med Liege; 2002 Apr; 57(4):196-201. PubMed ID: 12073790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]